U.S. General Merchandise and Department Stores Stock News

NasdaqGS:SONO
NasdaqGS:SONOConsumer Durables

Discovering 3 Stocks That Might Be Priced Below Their Estimated Intrinsic Value

Over the last 7 days, the United States market has remained flat, yet over the past 12 months, it has risen by an impressive 20%, with earnings forecasted to grow by 18% annually. In this context of steady growth and positive earnings outlooks, identifying stocks that might be priced below their estimated intrinsic value can present potential opportunities for investors seeking to capitalize on market inefficiencies.
NasdaqCM:CXDO
NasdaqCM:CXDOIT

3 Promising Growth Companies With Insider Ownership Up To 35%

The United States market remained flat over the last week but has experienced a 20% increase over the past year, with earnings forecast to grow by 18% annually. In this environment, growth companies with significant insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business.
NasdaqCM:TVRD
NasdaqCM:TVRDPharmaceuticals

Top Penny Stocks To Watch In July 2026

In the last week, the market has stayed flat, but it is up 20% over the past year, with earnings expected to grow by 18% per annum over the next few years. For those looking to invest in smaller or newer companies, penny stocks — despite being a somewhat outdated term — can still offer surprising value. In this article, we spotlight several penny stocks that stand out for their financial strength and potential for long-term success amidst current market conditions.
NasdaqGS:CME
NasdaqGS:CMECapital Markets

Top Dividend Stocks To Consider In July 2026

In the last week, the United States market has stayed flat, but over the past 12 months, it has seen a notable rise of 20%, with earnings expected to grow by 18% annually in the coming years. In such an environment, dividend stocks that offer consistent income and potential for capital appreciation can be appealing options for investors seeking stability and growth.
NasdaqGM:TMDX
NasdaqGM:TMDXMedical Equipment

TransMedics Group (TMDX) Expands Into Europe, Is The Stock Still Undervalued?

TransMedics Group (TMDX) has closed an investment in Germany based PAD Aviation, aiming to replicate its Organ Care System Network Operating Platform across Europe and build a dedicated pan European organ transplant logistics network. See our latest analysis for TransMedics Group. At a share price of US$71.12, TransMedics Group has seen the stock climb 7.07% over the past week and 2.43% over the past month, but it remains down 42.04% year to date and the 1 year total shareholder return has...
NasdaqGS:MGTX
NasdaqGS:MGTXBiotechs

MeiraGTx Holdings (MGTX) Is Up 8.5% After Securing US$425M In New Funding Pathways – Has The Bull Case Changed?

MeiraGTx Holdings plc recently entered into a private placement agreement to issue 2,376,426 ordinary shares at US$10.52 each for US$25,000,000 in gross proceeds, with closing of the initial sale having occurred in the past on July 17, 2026, and investors retaining the option to purchase up to an additional US$15,000,000 in shares under Regulation D. Alongside a separate agreement for up to US$400,000,000 in funding from Oberland Capital, this mix of non-dilutive royalties and new equity...
NYSE:HG
NYSE:HGInsurance

Should Hamilton Insurance Group’s Diverging Russell Exit and Zacks Upgrade Require Action From HG Investors?

Hamilton Insurance Group, Ltd. was recently dropped from the Russell 2000 Dynamic Index but, on July 7, 2026, was added to the Zacks Rank #1 (Strong Buy) List following an 18.5% upward revision in current‑year earnings estimates over the past 60 days. This combination of index exclusion and a Zacks upgrade highlights how differing frameworks can simultaneously reduce passive index exposure while signaling increased analyst confidence in the company’s earnings outlook. Next, we’ll examine how...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Ultragenyx Pharmaceutical (RARE) Is Up 7.4% After Index Migration To Russell 2000 And Value Benchmarks - Has The Bull Case Changed?

On 27 June 2026, Ultragenyx Pharmaceutical Inc. was removed from larger-cap Russell 1000 and Midcap indices and simultaneously added to the Russell 2000, related growth and value benchmarks, and several Russell value indices, reflecting a broad reclassification within the Russell index family. This reshuffling across size and style indices can materially influence trading flows as index-tracking and benchmark-aware investors adjust their portfolios to the new compositions. With Ultragenyx...
NYSE:ES
NYSE:ESElectric Utilities

Massachusetts Grid-Scale Batteries Might Change The Case For Investing In Eversource Energy (ES)

Eversource Energy, alongside National Grid and Unitil, has filed long-term contracts for three utility-scale battery storage projects in Massachusetts, totaling 1,068 MW and 4,472 MWh of capacity expected online by 2030 to support cleaner, more flexible grid operations. This large storage build-out marks a key step in Massachusetts’ push toward 5 GW of storage by 2030, highlighting Eversource’s expanding role in enabling clean peaking capacity and easing transmission congestion in Greater...
NasdaqGS:RPRX
NasdaqGS:RPRXPharmaceuticals

Royalty Pharma (RPRX) Could Be 2% Undervalued On Russell 1000 Defensive Index Addition

Royalty Pharma (RPRX) has just been added to both the Russell 1000 Value-Defensive Index and the Russell 1000 Defensive Index, a shift that often attracts closer attention from index-tracking and passive funds. See our latest analysis for Royalty Pharma. That index inclusion comes after a period of strong momentum for Royalty Pharma, with a 90-day share price return of 20.67%, a year-to-date share price return of 48.74%, and a 1-year total shareholder return of 66.26%. If you are using this...
NYSE:NET
NYSE:NETIT

US Stock Market Today: S&P 500 Futures Slip As Oil And Services Strengthen

The Morning Bull - US Market Morning Update Wednesday, Jul, 8 2026 US stock futures are mixed this morning, with E-mini S&P 500 contracts slightly softer while Dow futures edge higher, as investors weigh fresh signals on inflation and growth. Oil is back above $72 a barrel after tensions in the Strait of Hormuz, which makes fuel more expensive to transport and feeds worries that the cost of living could stay higher for longer. At the same time, the ISM Services PMI at 54.0 shows the largest...
NasdaqGS:GO
NasdaqGS:GOConsumer Retailing

Is Grocery Outlet Holding (GO) Fully Valued As Index Removal Shifts Attention?

Index removal puts fresh attention on Grocery Outlet Holding Grocery Outlet Holding (GO) was recently removed from both the Russell 2000 Defensive and Russell 2000 Value-Defensive indexes, an index reshuffle that can prompt trading shifts as benchmarked funds rebalance positions. See our latest analysis for Grocery Outlet Holding. For context, Grocery Outlet Holding’s share price has moved to US$10.21, with a 30-day share price return of 19.28% and a 90-day share price return of 43.80%...
NasdaqGS:LAES
NasdaqGS:LAESSemiconductor

SEALSQ (LAES) Reaffirms Growth Outlook Following Quantum Push As Fair Value Debate Builds

SEALSQ guidance and quantum roadmap draw investor focus SEALSQ (LAES) has reaffirmed its 2026 revenue guidance of 50% to 100% growth on audited 2025 revenue of US$18.3 million, while pushing ahead with its post-quantum cryptography product and readiness strategy. See our latest analysis for SEALSQ. Despite SEALSQ’s guidance reaffirmation and progress on its post quantum roadmap, the stock’s recent momentum has cooled, with the share price down 12.5% over 30 days and the year to date share...
NasdaqGS:MELI
NasdaqGS:MELIMultiline Retail

Is MercadoLibre (NasdaqGS:MELI) Trading At A Discount Or A Premium?

MercadoLibre’s share price has delivered a 61.7% gain over the past three years, yet its valuation signals are pulling in different directions, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to upside while market multiples suggest the stock trades at a premium. A 61.7% return over three years suggests MercadoLibre has already rewarded investors who stayed the course. This naturally raises the bar for what counts as good value today. Recent coverage...
NasdaqCM:SHAZ
NasdaqCM:SHAZIT

AI Small Cap Stocks Riding The Next Wave Of Compute And Voice Demand

With inflation, interest rate debates and energy shocks all pulling markets in different directions, investors are looking for clearer, more focused ideas. The AI Small Caps screener targets smaller companies that are building early-stage tools in areas such as machine learning, automation and data intelligence. These companies are at a stage where growth potential can still be influenced by new products and adoption. This article highlights 3 stocks from that screener, giving you a curated...
NasdaqGM:AUPH
NasdaqGM:AUPHBiotechs

Aurinia Pharmaceuticals (AUPH) Launches PRESERVE Study, Is A 5% Undervalued View Enough?

Aurinia Pharmaceuticals (AUPH) is drawing fresh attention after announcing PRESERVE, a Phase 4 multicenter study testing its oral lupus nephritis drug LUPKYNIS alongside three established immune therapies. See our latest analysis for Aurinia Pharmaceuticals. The PRESERVE announcement comes after a strong period for Aurinia Pharmaceuticals, with a 1 year total shareholder return of 113.70% and a more moderate 5.67% year to date share price return. This suggests momentum that investors are now...
NasdaqGS:LAMR
NasdaqGS:LAMRSpecialized REITs

Lamar’s Expanded Russell Value Index Footprint Could Be A Game Changer For Lamar Advertising (LAMR)

On 27 June 2026, Lamar Advertising was added to multiple Russell value indices and benchmarks, while being removed from the Russell 1000 Dynamic Index, reshaping its index footprint across value and mid-cap segments. This broad inclusion across Russell value and defensive indices can meaningfully influence how institutional investors classify Lamar within portfolios focused on value-oriented real estate exposure. We’ll now examine how Lamar’s expanded presence in major Russell value indices...
NYSE:HRL
NYSE:HRLFood

Beyond Meat Stock And 2 Protein Plays To Watch After Brazilian Beef Tariff Relief

Global protein markets are being shaken by the Trump administration’s decision to exempt Brazilian beef from proposed 25% tariffs, and that ripple is reaching well beyond ranches. For investors, this kind of trade shock can quickly reshuffle pricing power, costs and demand across traditional meat producers and consumer protein alternatives. This article breaks down three stocks exposed to the news, highlighting one that could see a potential tailwind from shifting consumer preferences and two...